Long-term outcomes of surgery and radiotherapy for secreting and non-secreting pituitary adenoma
Mi Young Kim, Jin Hee Kim, Young Kee Oh, El Kim
Radiat Oncol J. 2016;34(2):121-127.   Published online 2016 Jun 17     DOI: https://doi.org/10.3857/roj.2016.01683
Citations to this article as recorded by Crossref logo
Tumor shrinkage in a tamoxifen-treated non-functioning pituitary neuroendocrine tumor with positive estrogen receptor-beta (ERβ): A case report and review of the literature
Haydar Ali Tajuddin Amalina, Sukor Norlela, Azizan Elena Aisha, Kamaruddin Nor Azmi, Omar Ahmad Marzuki, Geok Chin Tan, Mustangin Muaatamarulain, Mohamed Mukari Shahizon Azura, Alias Azmi, Abd Latif Kartikasalwah, Poh Sen Tay, Idris Nurdillah, Kasim Fauzi
Journal of Clinical and Translational Endocrinology: Case Reports.2024; 33: 100174.     CrossRef
scRNA sequencing technology for PitNET studies
Walaa Asaad, Marina Utkina, Anastasia Shcherbakova, Sergey Popov, Galina Melnichenko, Natalia Mokrysheva
Frontiers in Endocrinology.2024;[Epub]     CrossRef
Radiotherapy and Mortality in Pituitary Adenomas
Baldomero González-Virla, Guadalupe Vargas-Ortega, Carlos Alfonso Romero-Gameros
Archives of Medical Research.2023; 54(8): 102900.     CrossRef
Correlation Analysis of Magnetic Resonance Imaging Characteristics and Prognosis of Invasive Pituitary Adenomas in Neurosurgery Hospitals
Jinan Bai, Xin Li, Ailiang Ge, Jianhua Gu, Yang Gao
Journal of Healthcare Engineering.2022; 2022: 1.     CrossRef
Stereotactic radiosurgery with or without surgical resection for pituitary adenoma: Insights from the National Cancer Database
Andre E. Boyke, Mohammed Ali Alvi, Abigail Funari, Ishan Naidu, Edward R. Bader, Vijay Agarwal
Interdisciplinary Neurosurgery.2022; 30: 101653.     CrossRef
Transcranial approach as surgical treatment for giant pituitary adenoma during COVID 19 pandemic – What can we learn?: A case report
Nyoman Golden, Wayan Niryana, Steven Awyono, Putu Eka Mardhika, Made Bhuwana Putra, Made Stefanus Biondi
Interdisciplinary Neurosurgery.2021; 25: 101153.     CrossRef
TBR-760, a Dopamine-Somatostatin Compound, Arrests Growth of Aggressive Nonfunctioning Pituitary Adenomas in Mice
Heather A Halem, Ute Hochgeschwender, Jeong Keun Rih, Richard Nelson, G Allan Johnson, Arunthi Thiagalingam, Michael D Culler
Endocrinology.2020;[Epub]     CrossRef
Evaluation of Complications and Costs During Overlapping Transsphenoidal Surgery in the Treatment of Pituitary Adenoma
Michael Karsy, Christian A Bowers, Jonathan Scoville, Bornali Kundu, Mohammed A Azab, J Michael Gee, Jian Guan, William T Couldwell
Neurosurgery.2019; 84(5): 1104.     CrossRef
Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma
Rafael L. Batista, Nina R.C. Musolino, Valter A.S. Cescato, Gilberto O. da Silva, Raphael S.S. Medeiros, Clarissa G.B. Herkenhoff, Ericka B. Trarbach, Malebranche B. Cunha-Neto
American Journal of Clinical Oncology.2019; 42(2): 221.     CrossRef
Development and validation of an MRI-based radiomic signature for the preoperative prediction of treatment response in patients with invasive functional pituitary adenoma
Yanghua Fan, Zhenyu Liu, Bo Hou, Longfei Li, Xiaohai Liu, Zehua Liu, Renzhi Wang, Yusong Lin, Feng Feng, Jie Tian, Ming Feng
European Journal of Radiology.2019; 121: 108647.     CrossRef
Updates in outcomes of stereotactic radiation therapy in acromegaly
Monica Livia Gheorghiu
Pituitary.2017; 20(1): 154.     CrossRef
MANEJO DE LOS TUMORES DE HIPÓFISIS
David Rojas
Revista Médica Clínica Las Condes.2017; 28(3): 409.     CrossRef
On-site audits to investigate the quality of radiation physics of radiation therapy institutions in the Republic of Korea
Jong Min Park, So-Yeon Park, Minsoo Chun, Sang-Tae Kim
Physica Medica.2017; 40: 110.     CrossRef